Evaxion Biotech A/S
EVAX
$1.65
$0.063.77%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.95M | 7.99M | 5.58M | 2.61M | 2.61M |
| Total Receivables | 1.86M | 790.00K | 1.08M | 781.00K | 781.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 955.00K | 1.92M | 1.69M | 3.35M | 3.35M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 117.00K | 117.00K |
| Total Current Assets | 8.77M | 10.70M | 8.35M | 6.85M | 6.85M |
|
|
|||||
| Total Current Assets | 8.77M | 10.70M | 8.35M | 6.85M | 6.85M |
| Net Property, Plant & Equipment | 3.51M | 3.90M | 4.34M | 4.31M | 4.31M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 206.00K | 628.00K | 196.00K | 777.00K | 777.00K |
| Total Assets | 12.49M | 15.23M | 12.89M | 11.94M | 11.94M |
|
|
|||||
| Total Accounts Payable | 2.97M | 2.56M | 2.69M | 2.61M | 2.61M |
| Total Accrued Expenses | 860.00K | -- | 894.00K | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 473.00K | 477.00K | 485.00K | 461.00K | 461.00K |
| Total Finance Division Other Current Liabilities | 67.00K | 786.00K | 3.02M | 1.62M | 1.62M |
| Total Other Current Liabilities | 67.00K | 786.00K | 3.02M | 1.62M | 1.62M |
| Total Current Liabilities | 4.37M | 3.82M | 7.08M | 4.69M | 4.69M |
|
|
|||||
| Total Current Liabilities | 4.37M | 3.82M | 7.08M | 4.69M | 4.69M |
| Long-Term Debt | 8.01M | 8.26M | 8.49M | 7.99M | 7.99M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.62M | 1.75M | 1.90M | 1.86M | 1.86M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 141.00K | 145.00K | 149.00K | 143.00K | 143.00K |
| Total Liabilities | 14.14M | 13.98M | 17.62M | 14.68M | 14.68M |
|
|
|||||
| Common Stock & APIC | 106.46M | 104.12M | 93.35M | 90.56M | 90.56M |
| Retained Earnings | -118.54M | -112.97M | -107.97M | -89.76M | -89.76M |
| Treasury Stock & Other | 10.43M | 10.10M | 9.89M | -3.53M | -3.53M |
| Total Common Equity | -1.65M | 1.25M | -4.73M | -2.73M | -2.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.65M | 1.25M | -4.73M | -2.73M | -2.73M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.65M | 1.25M | -4.73M | -2.73M | -2.73M |
|
|
|||||